| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 158,360 | 161,643 | 165,757 | 160,927 | | Cost of Revenue | 49,564 | 48,815 | 54,022 | 54,654 | | | Gross Profit | 108,796 | 112,828 | 111,735 | 106,273 | | | Operating Expenses | | Research Development | 34,405 | 33,117 | 32,726 | 28,338 | | Selling General and Administrative | 42,096 | 41,939 | 42,831 | 39,206 | | Non Recurring | 1,325 |
-
|
-
|
-
| | Others | 1,670 | 1,670 | 1,670 | 2,653 | | | | Total Operating Expenses | 79,496 |
-
|
-
|
-
| | | | Operating Income or Loss | 29,300 | 36,102 | 34,508 | 36,076 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 5,663 | | Earnings Before Interest And Taxes | 21,227 | 36,102 | 34,508 | 41,739 | | Interest Expense | (6,236) | 1,079 | 5,157 | 2,070 | | Income Before Tax | 27,463 | 35,023 | 29,351 | 39,669 | | Income Tax Expense | 10,386 | 10,335 | 10,540 | 10,730 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 17,077 | 24,688 | 18,811 | 28,939 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 17,077 | 24,688 | 18,811 | 28,939 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $17,077 | $24,688 | $18,811 | $28,939 |
|
1.48% Nasdaq 
Income Statement
